Double Blinded Randomized Controlled Trial of Intranasal Dexmedetomidine Versus Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair in the Emergency Department
Phase of Trial: Phase IV
Latest Information Update: 14 Mar 2017
Price : $35 *
At a glance
- Drugs Dexmedetomidine (Primary) ; Midazolam
- Indications Anxiety
- Focus Therapeutic Use
- 20 Jan 2017 Status changed from active, no longer recruiting to completed.
- 14 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Apr 2015, as reported by ClinicalTrials.gov.
- 14 Jan 2016 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.